Riboscience, Llc.
Clinical trials sponsored by Riboscience, Llc., explained in plain language.
-
New drug aims to unleash immune system on Hard-to-Treat tumors
Disease control Recruiting nowThis early-phase study tests an experimental drug called RBS2418, which works by helping the body's immune system fight cancer more effectively. It is given alone or with another immunotherapy (pembrolizumab) to adults with advanced solid tumors that have not responded to standar…
Phase: PHASE1 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy aims to boost immune attack on liver tumors
Disease control Recruiting nowThis study tests a new drug called RBS2418 combined with two immunotherapy drugs (tremelimumab and durvalumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination helps shrink tumors or slows cancer growth better than the…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to rev up immune system against tough colon cancer
Disease control Recruiting nowThis study tests an experimental drug called RBS2418 in 150 adults with advanced colorectal cancer that has spread and is no longer responding to standard treatments. The drug works by helping the immune system recognize and attack cancer cells. Participants will receive either R…
Phase: PHASE2 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC